UK industry agrees flexible five-year price plan after cuts – update
This article was originally published in Scrip
Executive Summary
The UK pharmaceutical industry and the government have reached agreement on a new five-year pharmaceutical price regulation scheme (PPRS) that revises rather than rewrites the system that has governed drug pricing in the UK for 50 years. When the government announced last year that it was scrapping the PPRS, many in industry feared a radical overhaul, but the version mostly finalised this week retains the principal elements of the original scheme.